CCND1 and cancer: Upon activation, however, it can trigger the transcription of related target genes such as Bcl-2, matrix metalloproteinases, cyclin D1, and survival proteins, which can inhibit tumor cell apoptosis, promote normal cell transformation, induce tumor angiogenesis and metastasis, and trigger the development of malignant tumors.